These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25161158)

  • 21. Pharmacy-based predictors of non-persistence with and non-adherence to statin treatment among patients on oral diabetes medication in the Netherlands.
    Alfian SD; Worawutputtapong P; Schuiling-Veninga CCM; van der Schans J; Bos JHJ; Hak E; Denig P
    Curr Med Res Opin; 2018 Jun; 34(6):1013-1019. PubMed ID: 29292657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statin adherence and mortality in patients enrolled in a secondary prevention program.
    McGinnis BD; Olson KL; Delate TM; Stolcpart RS
    Am J Manag Care; 2009 Oct; 15(10):689-95. PubMed ID: 19845421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of medication adherence on long-term all-cause-mortality and hospitalization for cardiovascular disease in 65,067 newly diagnosed type 2 diabetes patients.
    Kim YY; Lee JS; Kang HJ; Park SM
    Sci Rep; 2018 Aug; 8(1):12190. PubMed ID: 30111867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The beneficial effects of statins in patients undergoing hemodialysis.
    Huang CC; Chan WL; Chen YC; Chen TJ; Chung CM; Huang PH; Lin SJ; Chen JW; Leu HB
    Int J Cardiol; 2013 Oct; 168(4):4155-9. PubMed ID: 23928338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Community Pharmacy-Based Inducement Programs Associated With Better Medication Adherence: A Cohort Study.
    Simpson SH; Lin M; Eurich DT
    Ann Pharmacother; 2017 Aug; 51(8):630-639. PubMed ID: 28372491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs.
    Dragomir A; Côté R; Roy L; Blais L; Lalonde L; Bérard A; Perreault S
    Med Care; 2010 May; 48(5):418-25. PubMed ID: 20393367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Adherence to Statin Therapy on Health Care Outcomes and Utilizations in Taiwan: A Population-Based Study.
    Li YC; Huang WL
    Biomed Res Int; 2015; 2015():149573. PubMed ID: 26539464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compliance and persistence with concomitant statin and oral antihyperglycemic therapy.
    Zhang Q; Zhao C; Davies MJ; Radican L; Seck T
    Am J Manag Care; 2011 Nov; 17(11):746-52. PubMed ID: 22084894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statins, risk of diabetes, and implications on outcomes in the general population.
    Wang KL; Liu CJ; Chao TF; Huang CM; Wu CH; Chen SJ; Chen TJ; Lin SJ; Chiang CE
    J Am Coll Cardiol; 2012 Oct; 60(14):1231-8. PubMed ID: 22884288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.
    Heintjes EM; Penning-van Beest FJ; Plat AW; Meerding WJ; Webb K; Sturkenboom MC; Herings RM
    Pharmacotherapy; 2012 Jul; 32(7):631-41. PubMed ID: 22760692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statins after recent stroke reduces recurrence and improves survival in an aging Mediterranean population without known coronary heart disease.
    Sicras-Mainar A; Planas-Comes A; Frias-Garrido X; Navarro-Artieda R; de Salas-Cansado M; Rejas-Gutiérrez J
    J Clin Pharm Ther; 2012 Aug; 37(4):441-7. PubMed ID: 22059532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel.
    Chodick G; Shalev V; Gerber Y; Heymann AD; Silber H; Simah V; Kokia E
    Clin Ther; 2008 Nov; 30(11):2167-79. PubMed ID: 19108805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Antihypertensive Medication Adherence With Healthcare Use and Medicaid Expenditures for Acute Cardiovascular Events.
    Yang Z; Howard DH; Will J; Loustalot F; Ritchey M; Roy K
    Med Care; 2016 May; 54(5):504-11. PubMed ID: 27078823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does a cardiovascular event change adherence to statin treatment in patients with type 2 diabetes? A matched cohort design.
    de Vries FM; Denig P; Vegter S; Bos HJ; Postma MJ; Hak E
    Curr Med Res Opin; 2015 Apr; 31(4):595-602. PubMed ID: 25629791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of adherence to statin therapy on cardiovascular mortality: quantification of unmeasured bias using falsification end-points.
    Bijlsma MJ; Vansteelandt S; Janssen F; Hak E
    BMC Public Health; 2016 Apr; 16():303. PubMed ID: 27067123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Family history of cardiovascular disease and influence on statin therapy persistence.
    Citarella A; Kieler H; Sundström A; Linder M; Wettermark B; Berglind IA; Andersen M
    Eur J Clin Pharmacol; 2014 Jun; 70(6):701-7. PubMed ID: 24604354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adherence to statins and LDL-cholesterol goal attainment.
    Chi MD; Vansomphone SS; Liu IL; Cheetham C; Green KR; Scott RD; Reynolds K
    Am J Manag Care; 2014 Apr; 20(4):e105-12. PubMed ID: 24884955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated risk of death and major cardiovascular events in subjects with newly diagnosed diabetes: findings from an administrative database.
    Monesi L; Tettamanti M; Cortesi L; Baviera M; Marzona I; Avanzini F; Monesi G; Nobili A; Riva E; Fortino I; Bortolotti A; Fontana G; Merlino L; Trevisan R; Roncaglioni MC
    Nutr Metab Cardiovasc Dis; 2014 Mar; 24(3):263-70. PubMed ID: 24418374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lower risk of major cardiovascular events associated with adherence to colesevelam HCI.
    Ye X; Qian C; Liu J; St Peter WL
    Pharmacotherapy; 2013 Oct; 33(10):1062-70. PubMed ID: 23798059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between adherence level to statins, clinical issues and health-care costs in real-life clinical setting.
    Dragomir A; Côté R; White M; Lalonde L; Blais L; Bérard A; Perreault S
    Value Health; 2010; 13(1):87-94. PubMed ID: 19695008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.